Lineage Therap(IL:LCTX)
ILA 346.60+20.90 (+6.42%)
IL:LCTX
Lineage Therap earnings date
ILA 346.60
At close:+20.90 (+6.42%)
Lineage Therap (LCTX) Q2 2024 Earnings Report
3 Followers
IL:LCTX Q2 2024 EPS Results
- Actual EPS
- -ILA 9.58
- Consensus EPS
- -ILA 14.37
- Beat/Miss
- Beat by +ILA 4.79
- One Year Ago EPS
- -ILA 9.58
IL:LCTX Q2 2024 Revenue Results
- Actual Revenue
- ILA 449.50M
- Expected Revenue
- ILA 301.05M
- Beat/Miss
- Beat by +ILA 148.45M
- YoY Revenue Growth
- -56.34%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/08/2024
- Time
- After Close
- Conference Call
- Thursday, August 8, 2024
IL:LCTX Upcoming Earnings
Lineage Therap's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
IL:LCTX Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
IL:LCTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | -5.43- | 1.28 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -9.26-9.58 | -41.5 | 76.92% (+31.93) | |
| Aug 06, 2026 | 2026 (Q2) | -8.94-9.58 | -41.5 | 76.92% (+31.93) | |
| May 12, 2026 | 2026 (Q1) | -6.39-9.58 | -6.39 | -50.00% (-3.19) | |
| Mar 05, 2026 | 2025 (Q4) | -13.731.28 | -6.39 | 120.00% (+7.66) | |
| Nov 06, 2025 | 2025 (Q3) | -8.30-41.50 | -6.39 | -550.00% (-35.12) | |
| Aug 12, 2025 | 2025 (Q2) | -8.62-41.50 | -9.58 | -333.33% (-31.93) | |
| May 13, 2025 | 2025 (Q1) | -8.30-6.39 | -12.77 | 50.00% (+6.39) | |
| Mar 10, 2025 | 2024 (Q4) | -9.58-6.39 | -9.58 | 33.33% (+3.19) | |
| Nov 14, 2024 | 2024 (Q3) | -12.77-6.39 | -12.77 | 50.00% (+6.39) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
